Rapid and Accurate Detection of SARS-CoV-2 Using an iPad-Controlled, High-Throughput, Portable, and Multiplex Hi ve-Chip Platform ( Hi Cube).
Yuanshou ZhuNelson OdiwuorZigan ShaYanjing ChenNing ShaoXudong WuJianwei ChenYang LiShujuan GuoDawei ShiPeng LiuYan ZhangHongping WeiSheng-Ce TaoPublished in: ACS sensors (2023)
Rapid and accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the most effective measures to control the coronavirus disease 2019 (COVID-19) pandemic. However, there is still lack of an ideal detection platform capable of high sample throughput, portability, and multiplicity. Herein, by combining Hive-Chip (capillary microarray) and reverse transcriptional loop-mediated isothermal amplification (RT-LAMP), we developed an iPad-controlled, high-throughput (48 samples at one run), portable (smaller than a backpack), multiplex (monitoring 8 gene fragments in one reaction), and real-time detection platform for SARS-CoV-2 detection. This platform is composed of a portable Hi ve-Chip device ( Hi Cube; 32.7 × 29.7 × 20 cm, 5 kg), custom-designed software, and optimized Hive-Chips. RT-LAMP primers targeting seven SARS-CoV-2 genes (S, E, M, N, ORF1ab, ORF3a, and ORF7a) and one positive control (human RNase P) were designed and prefixed in the Hive-Chip. On-chip RT-LAMP showed that the limit of detection (LOD) of SARS-CoV-2 synthetic RNAs is 1 copy/μL, and there is no cross-reaction among different target genes. The platform was validated by 100 clinical samples of SARS-CoV-2, and the results were highly consistent with those of the traditional real-time PCR assay. In addition, on-chip detection of 6 other respiratory pathogens showed no cross-reactivity. Overall, our platform has great potential for fast, accurate, and on-site detection of SARS-CoV-2.
Keyphrases
- loop mediated isothermal amplification
- high throughput
- sars cov
- respiratory syndrome coronavirus
- real time pcr
- sensitive detection
- coronavirus disease
- single cell
- high resolution
- circulating tumor cells
- label free
- dna methylation
- genome wide
- endothelial cells
- risk assessment
- oxidative stress
- multidrug resistant
- climate change